Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02288819Terminated
Open-label trial of furosemide, bumetanide and torasemide in heart failure (HF), sponsored by Hasselt University. Primary endpoint: Number of Participants With Successful Downtitration of Loop Diuretics (no Weight Increase >1,5 kg) at 7 days. Started Sep 2014; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02288819.